Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.

Size: px
Start display at page:

Download "Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York."

Transcription

1 A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling Brown T J, Hooper L, Elliott R A, Payne K, Webb R, Roberts C, Rostom A, Symmons D CRD summary This review concluded that misoprostol, cyclooxygenase-2 (COX-2) and selective non-steroidal anti-inflammatory drugs (NSAIDs), and possibly proton-pump inhibitors, reduce the risk of symptomatic ulcers; misoprostol is less well tolerated than proton-pump inhibitors or COX-2 non-steroidal anti-inflammatory drugs; and proton-pump inhibitors reduce the incidence of gastrointestinal symptoms, but not serious gastrointestinal complications, compared with COX-2 NSAIDs. The authors' conclusions seem reliable. Authors' objectives To assess the effectivenes of five specified gastroprotective strategies for people taking non-steroidal anti-inflammatory drugs (NSAIDs). Searching The Cochrane Library (Issue 2, 2002), MEDLINE (1966 to 2002), EMBASE (1980 to 2002), Current Controlled Trials (2002) and SIGLE (2002) were searched. The search terms were given on the NHS Health Technology Assessment Programme website (accessed 25/06/2005). See Web Address at end of abstract. In addition, the reference lists of included studies and identified systematic reviews were checked and authors were contacted for additional studies. Non- English reports were eligible. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) of at least 21 days in duration were eligible for inclusion. Specific interventions included in the review Studies that compared one of the following gastroprotective strategies with non-selected NSAIDs alone were eligible for inclusion: non-selective NSAID plus histamine-2 receptor antagonists (H2RAs); non-selective NSAID plus protonpump inhibitors (PPIs); non-selective NSAID plus misoprostol; cyclooxygenase-2 (COX-2) selective NSAID only; or COX-2 specific NSAID only. The authors stated that some of the included studies used NSAIDs and gastroprotective agents at higher than the recommended doses. Participants included in the review Studies that evaluated exclusively children or healthy volunteers were excluded. The baseline gastrointestinal (GI) status (based on a score of 1 to 6, and defined as the percentage of patients with history of ulcers or bleeds) varied across the included studies. Further details were reported. Outcomes assessed in the review The primary outcomes of interest were serious GI complications, symptomatic ulcers, serious cardiovascular or renal illness, health-related quality of life (not measures of arthritis pain or disability) and mortality. GI complications included haemorrhage, haemorrhagic erosions, recurrent upper GI bleeds, perforation, pyloric obstruction and melaena. The secondary outcomes of interest included total GI symptoms, endoscopic ulcers, anaemia, occult bleeding, the total number of drop-outs and drop-outs due to GI symptoms. How were decisions on the relevance of primary studies made? Two reviewers independently selected the studies and resolved any disagreements through discussion. Page: 1 / 5

2 Assessment of study quality The studies were assessed for methods of randomisation, allocation concealment, baseline comparability, blinding of the participants, care providers and outcome assessors, and losses to follow-up. Studies were classified for risk of bias (low, medium or high) based on allocation concealment and baseline comparability. Two reviewers independently assessed validity and resolved any disagreements through discussion. Data extraction Two reviewers independently extracted the data and resolved any disagreements through discussion. For each comparison, data were extracted on the number of people with each outcome for the longest follow-up point and used to derive a relative risk (RR). Methods of synthesis How were the studies combined? The results from the individual studies were combined using a random-effects meta-analysis, where appropriate. A pooled RR with 95% confidence intervals (CIs) was calculated separately for each gastroprotective strategy for each outcome of interest. The number-needed-to-treat to prevent one symptomatic ulcer was calculated where data permitted. Publication bias was assessed using funnel plots and Egger's and Begg's tests. How were differences between studies investigated? Statistical heterogeneity was assessed using the Cochran test (with a significance level of p<0.1) and by visual assessment of forest plots. A random-effects meta-regression was used to examine the influence on symptomatic ulcers of length of follow-up, mean age of the participants, baseline GI status and a number of initial risk factors for GI harms. A sensitivity analysis was performed by omitting studies with a 'high' risk of bias, treatment arms with higher than recommended doses of NSAID or gastroprotective agent, and naproxen treatment arms (for deaths and serious cardiovascular and renal events). Results of the review One hundred and eighteen RCTs (n=76,322) were included. Five studies were considered to be at low risk for bias. Methodological flaws of the studies included lack of systematic reporting of important outcomes, overlapping of some outcomes, and lack of reporting allocation concealment and blinding of the outcomes assessment. The authors stated that few authors provided, or were able to provide, additional data when contacted and that few studies did not receive funding from pharmaceutical companies. Non-selective NSAID plus H2RA versus placebo plus non-selective NSAID: 15 RCTs (2,621 patients) were identified, none of which were judged to be at low risk of bias. There were insufficient data to adequately compare H2RAs with placebo on any of the primary outcomes. H2RAs significantly reduced endoscopic ulcers compared with placebo (RR 0.55, 95% CI: 0.4, 0.7). Non-selective NSAID plus PPIs versus placebo plus non-selective NSAID: 6 RCTs (1,358 patients) were identified, one of which was judged to be at low risk of bias. There were insufficient data to compare PPIs with placebo in terms of serious GI complications, serious cardiovascular or renal conditions, quality of life, or death. The significant reduction in symptomatic ulcers with PPI versus placebo (RR 0.09, 95% CI: 0.0, 0.5) was lost on sensitivity analysis. The significant reduction in endoscopic ulcers with PPI versus placebo (RR 0.37, 95% CI: 0.3, 0.5) remained on sensitivity analysis. Non-selective NSAID plus misoprostol versus placebo plus non-selective NSAID: 23 RCTs (16,945 patients) were identified, one of which was judged to be at low risk of bias. Misoprostol significantly reduced serious GI complications (RR 0.57, 95% CI: 0.4, 0.9), symptomatic ulcers (RR 0.36, 95% CI: 0.2, 0.7) and endoscopic ulcers (RR 0.33, 95% CI: 0.3, 0.4). No statistically significant heterogeneity was detected and the results were stable to sensitivity analysis. Page: 2 / 5

3 COX-2 selective NSAID only versus non-selective NSAIDs: 51 RCTs (28,178 patients) were identified, none of which were judged to be at low risk of bias. COX-2 selective NSAIDs significantly reduced symptomatic ulcers compared with placebo (RR 0.41, 95% CI: 0.3, 0.7). There were few events reported for the other primary outcomes. COX-2 specific NSAID only versus non-selective NSAIDs: 17 RCTs (25,564 patients) were identified, three of which were judged to be at low risk of bias. COX-2 specific NSAIDs appeared to significantly reduce serious GI complications (RR 0.55, 95% CI: 0.4, 0.8) and symptomatic ulcers (RR 0.49, 95% CI: 0.4, 0.6). No statistically significant heterogeneity was detected for either meta-analysis, but the results for serious GI complications were not robust to sensitivity analysis. No significant difference was found in the occurrence of serious cardiovascular or renal illness, or total deaths. COX-2 specific NSAIDs were associated with significantly fewer endoscopic ulcers. The meta-regression found no significant association between the RR of symptomatic ulcers (for COX-2 selectives and specifics) or endoscopic ulcers (for H2RAs, PPIs and misoprostol) and length of follow-up, mean age, or baseline GI status. The number-needed-to-treat was infinite for H2RAs and COX-2 specific NSAIDs and 14 (8 to 100) for PPIs. Following the initial writing of this abstract based on a paper (see Other Publications of Related Interest no.1), the full report has become available in which 10 further comparisons were reported. H2RA plus NSAID versus misoprostol plus NSAID (3 RCTs; at least 599 patients): significant results were not seen for any primary outcome, and the CIs were wide. The only secondary outcome to show a significant difference when H2RA and misoprostol were compared directly was endoscopic ulcers (RR 4.35, 95% CI: 1.51, 12.55; 3 RCTs). Misoprostol plus NSAID versus COX-2 preferential NSAID (3 RCTs; 1,035 patients): there was a significant increase in serious GI events with misoprostol (RR 3.05, 95% CI: 1.03, 9.06; 2 RCTs). There was no significant difference in serious cardiovascular or renal events or deaths (1 RCT). PPI plus NSAID versus misoprostol plus NSAID (2 RCTs; 973 patients): significant results were not seen for any primary outcome. Only single studies evaluating each of the following comparisons were identified: H2RA plus NSAID versus PPI plus NSAID; PPI plus NSAID versus COX-2 coxib NSAID; misoprostol plus NSAID versus COX-2 coxib NSAID; and COX-2 coxib NSAID versus COX-2 preferential NSAID. No studies were identified evaluating the following comparisons: H2RA plus NSAID versus COX-2 coxib NSAID or COX-2 preferential NSAID; and PPI plus NSAID versus COX-2 preferential NSAID. Cost information The economic analysis suggested that COX-1 NSAIDs plus H2RAs may reduce the risk of endoscopic ulcer at a lower overall cost to the health care provider than NSAIDs alone, and COX-1 NSAIDs plus PPIs or misoprostol and COX-2 coxibs at an overall increased cost. Authors' conclusions Misoprostol, COX-2 specific and selective NSAIDs, and possibly PPIs, significantly reduced the risk of symptomatic ulcers. Misoprostol and probably COX-2 specifics significantly reduced the risk of serious GI complications, but the quality of the data was poor. Misoprostol is not so well tolerated as either PPIs or a COX-2 NSAID. PPIs are probably more effective at reducing the incidence of GI symptoms, but not necessarily serious GI complications, compared with COX-2 NSAIDs. CRD commentary The review question was clear in terms of the study design, participants, intervention and outcomes. Several relevant sources were searched and the search terms were stated. Attempts were made to minimise language and publication Page: 3 / 5

4 bias. Two reviewers independently selected the studies, assessed validity and extracted the data, thus reducing the potential for bias and errors. Validity was assessed using established criteria. Adequate details on the results of the included studies were given, although information on the participants and interventions was limited. The methods used to combine the studies appeared appropriate. Differences between the studies were assessed and associations between treatment effect and several study characteristics were explored. The synthesis of the evidence took account of study quality. The authors' conclusions appear reliable. Implications of the review for practice and research Practice: The authors stated that patients in high-risk groups should either be co-prescribed a gastroprotective agent, or a COX-2 NSAID, and that there is no justification for co-prescribing a H2RA over the other strategies. Research: The authors stated that trials should report rare but important events (such as deaths, cardiovascular events or serious GI bleeds) in papers so that data are available for independent meta-analysis or, at the very least, are available to named contact authors. They further stated that there is a need for a large multicentre, independently funded trial lasting at least 1 year into gastroprotective agents such as H2RAs, PPIs, misoprostol, COX-2 selectives, COX-2 specifics and placebo. Funding NHS R&D Health Technology Assessment (HTA) Programme, project number 01/40/02. Bibliographic details Brown T J, Hooper L, Elliott R A, Payne K, Webb R, Roberts C, Rostom A, Symmons D. A comparison of the costeffectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. Health Technology Assessment 2006; 10(38): Original Paper URL Other publications of related interest 1. Hooper L, Brown TJ, Elliott RA, Payne K, Roberts C, Rostom A, et al. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti- inflammatory drugs: systematic review. BMJ 2004;329: Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ 2002;325: National Institute for Clinical Excellence. Guidance on the use of cyclo-oxygenase (COX) II selective inhibitors, celecoxib, refecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. London: The Institute; Report No.: Technology Appraisal Guidance 27. This additional published commentary may also be of interest. Wong VW. Review: misoprostol or COX-2-specific or selective NSAIDs reduce gastrointestinal complications and symptomatic ulcers. ACP J Club 2005;142:75. Indexing Status Subject indexing assigned by NLM MeSH Anti-Inflammatory Agents, Non-Steroidal /adverse effects /economics; Cost-Benefit Analysis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors /economics /therapeutic use; Gastrointestinal Diseases /chemically induced /economics /prevention & control; Great Britain; Humans; Isoenzymes /antagonists & inhibitors; Membrane Proteins; Models, Econometric; Patient Satisfaction; Prostaglandin-Endoperoxide Synthases; Proton Pumps /antagonists & inhibitors; Risk Factors AccessionNumber Page: 4 / 5

5 Powered by TCPDF ( Date bibliographic record published 31/01/2008 Date abstract record published 31/01/2008 Record Status This is a critical abstract of a systematic review that meets the criteria for inclusion on DARE. Each critical abstract contains a brief summary of the review methods, results and conclusions followed by a detailed critical assessment on the reliability of the review and the conclusions drawn. Page: 5 / 5

Setting The setting was the community. The economic study was carried out in the USA.

Setting The setting was the community. The economic study was carried out in the USA. Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis Yun H R, Bae S C Record

More information

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing. Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives

More information

Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam Tavakoli M

Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam Tavakoli M Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam Tavakoli M Record Status This is a critical abstract of an economic

More information

Setting The setting was primary and secondary care. The economic study was carried out in the UK.

Setting The setting was primary and secondary care. The economic study was carried out in the UK. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis Ford A C, Qume M, Moayyedi P, Arents N L, Lassen A T, Logan R F, McColl K E, Myres P,

More information

Source of effectiveness data The effectiveness data were derived from a review and synthesis of completed studies.

Source of effectiveness data The effectiveness data were derived from a review and synthesis of completed studies. Economic evaluation of maintenance therapies for reflux esophagitis: comparison between step-up therapies and step-down therapies Sugano K, Kobayashi M Record Status This is a critical abstract of an economic

More information

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein

More information

A systematic review of treatments for severe psoriasis Griffiths C E, Clark C M, Chalmers R J, Li Wan Po A, Williams H C

A systematic review of treatments for severe psoriasis Griffiths C E, Clark C M, Chalmers R J, Li Wan Po A, Williams H C A systematic review of treatments for severe psoriasis Griffiths C E, Clark C M, Chalmers R J, Li Wan Po A, Williams H C Authors' objectives To compare the effectiveness of currently available treatments

More information

Study selection Study designs of evaluations included in the review Diagnosis.

Study selection Study designs of evaluations included in the review Diagnosis. Diagnosis and treatment of worker-related musculoskeletal disorders of the upper extremity: epicondylitis Chapell R, Bruening W, Mitchell M D, Reston J T, Treadwell J R Authors' objectives The objectives

More information

2. The effectiveness of combined androgen blockade versus monotherapy.

2. The effectiveness of combined androgen blockade versus monotherapy. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer Blue Cross and Blue Shield Association, Aronson N, Seidenfeld J Authors' objectives

More information

Study population The study population comprised hypothetical patients with gastric and duodenal ulcer.

Study population The study population comprised hypothetical patients with gastric and duodenal ulcer. Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan Ikeda S, Tamamuro T, Hamashima C, Asaka M Record Status This is a critical

More information

Page: 1 / 5 Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York

Page: 1 / 5 Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York Weight management using a meal replacement strategy: meta and pooling analysis from six studies Heymsfield S B, van Mierlo C A, van der Knaap H C, Heo M, Frier H I CRD summary The review assessed partial

More information

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York.

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults Briss P A, Rodewald L E, Hinman A R, Shefer A M, Strikas R A, Bernier R R, Carande-Kulis

More information

Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were eligible for inclusion in the review.

Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were eligible for inclusion in the review. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses Stokman M A, Spijkervet F K, Boezen H M, Schouten J P, Roodenburg J L, de Vries

More information

Efficacy of postoperative epidural analgesia Block B M, Liu S S, Rowlingson A J, Cowan A R, Cowan J A, Wu C L

Efficacy of postoperative epidural analgesia Block B M, Liu S S, Rowlingson A J, Cowan A R, Cowan J A, Wu C L Efficacy of postoperative epidural analgesia Block B M, Liu S S, Rowlingson A J, Cowan A R, Cowan J A, Wu C L CRD summary This review evaluated the efficacy of post-operative epidural analgesia. The authors

More information

Source of effectiveness data The estimate for final outcomes was based on a synthesis of completed studies.

Source of effectiveness data The estimate for final outcomes was based on a synthesis of completed studies. Cost effectiveness, quality-adjusted life-years and supportive care: recombinant human erythropoietin as a treatment of cancer-associated anaemia Cremieux P, Finkelstein S N, Berndt E R, Crawford J, Slavin

More information

Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori Taylor J L, Zagari M, Murphy K, Freston J W

Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori Taylor J L, Zagari M, Murphy K, Freston J W Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori Taylor J L, Zagari M, Murphy K, Freston J W Record Status This is a critical abstract of an economic evaluation that

More information

Study population The study population comprised a hypothetical cohort of patients with confirmed reflux oesophagitis.

Study population The study population comprised a hypothetical cohort of patients with confirmed reflux oesophagitis. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK Wahlqvist P, Junghard O, Higgins A, Green J Record Status This is a critical

More information

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist.

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:

More information

Colour vision screening: a critical appraisal of the literature New Zealand Health Technology Assessment

Colour vision screening: a critical appraisal of the literature New Zealand Health Technology Assessment Colour vision screening: a critical appraisal of the literature New Zealand Health Technology Assessment Authors' objectives To provide an evidence-based review evaluating colour vision screening through

More information

Setting The setting was secondary care. The economic study was carried out in Hong Kong, China.

Setting The setting was secondary care. The economic study was carried out in Hong Kong, China. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis You J H, Wong

More information

Hyperbaric oxygen therapy Villanueva E, Johnston R, Clavisi O, Burrows E, Bernath V, Rajendran M, Wasiak J, Fennessy P, Anderson J, Harris A, Yong K

Hyperbaric oxygen therapy Villanueva E, Johnston R, Clavisi O, Burrows E, Bernath V, Rajendran M, Wasiak J, Fennessy P, Anderson J, Harris A, Yong K Hyperbaric oxygen therapy Villanueva E, Johnston R, Clavisi O, Burrows E, Bernath V, Rajendran M, Wasiak J, Fennessy P, Anderson J, Harris A, Yong K Authors' objectives To assess the effectiveness of hyperbaric

More information

Setting The setting was secondary care. The economic study was carried out in Hawaii, USA.

Setting The setting was secondary care. The economic study was carried out in Hawaii, USA. Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis: systematic re-evaluation of clinical evidence and drug cost implications

More information

Authors' objectives To evaluate the efficacy of intravenous immunoglobulin (IVIG) for neurologic conditions.

Authors' objectives To evaluate the efficacy of intravenous immunoglobulin (IVIG) for neurologic conditions. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review Fergusson D, Hutton B, Sharma M, Tinmouth A, Wilson K, Cameron D W, Hebert P C CRD summary This review assessed

More information

An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies Howard F M

An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies Howard F M An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies Howard F M Authors' objectives To assess the efficacy of treatment of endometriosis-associated

More information

Setting The setting was primary and secondary care. The economic study was carried out in the UK.

Setting The setting was primary and secondary care. The economic study was carried out in the UK. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom Wade A G, Toumi I, Hemels M E H Record Status This is a critical abstract of

More information

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia Kaplan-Machlis B, Spiegler G E, Zodet M W, Revicki

More information

Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?

Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs? et al. DOI:10.1111/j.1365-2125.2003.02012.x British Journal of Clinical Pharmacology Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs? Mary Teeling, Kathleen Bennett

More information

Alternative management strategies for patients with suspected peptic ulcer disease Fendrick M A, Chernew M E, Hirth R A, Bloom B S

Alternative management strategies for patients with suspected peptic ulcer disease Fendrick M A, Chernew M E, Hirth R A, Bloom B S Alternative management strategies for patients with suspected peptic ulcer disease Fendrick M A, Chernew M E, Hirth R A, Bloom B S Record Status This is a critical abstract of an economic evaluation that

More information

Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment Pohl H, Finlayson S R, Sonnenberg A, Robertson D J

Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment Pohl H, Finlayson S R, Sonnenberg A, Robertson D J Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment Pohl H, Finlayson S R, Sonnenberg A, Robertson D J Record Status This is a critical abstract of an economic

More information

Authors' objectives To evaluate the efficacy of complementary and alternative therapies for the management of menopausal symptoms.

Authors' objectives To evaluate the efficacy of complementary and alternative therapies for the management of menopausal symptoms. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review Nedrow A, Miller J, Walker M, Nygren P, Huffman L H, Nelson H D CRD summary This review

More information

Gastrointestinal Safety of Coxibs and Outcomes Studies: What s the Verdict?

Gastrointestinal Safety of Coxibs and Outcomes Studies: What s the Verdict? Vol. 23 No. 4S April 2002 Journal of Pain and Symptom Management S5 Proceedings from the Symposium The Evolution of Anti-Inflammatory Treatments in Arthritis: Current and Future Perspectives Gastrointestinal

More information

Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial Pinnock H, McKenzie L, Price D, Sheikh A

Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial Pinnock H, McKenzie L, Price D, Sheikh A Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial Pinnock H, McKenzie L, Price D, Sheikh A Record Status This is a critical abstract of an economic

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 38 Effective Health Care Program Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review Executive Summary Background Osteoarthritis

More information

Pamidronate in prevention of bone complications in metastatic breast cancer: a costeffectiveness

Pamidronate in prevention of bone complications in metastatic breast cancer: a costeffectiveness Pamidronate in prevention of bone complications in metastatic breast cancer: a costeffectiveness analysis Hillner B E, Weeks J C, Desch C E, Smith T J Record Status This is a critical abstract of an economic

More information

A cost-utility analysis of interferon beta for multiple sclerosis Parkin D, Miller P, McNamee P, Thomas S, Jacoby A, Bates D

A cost-utility analysis of interferon beta for multiple sclerosis Parkin D, Miller P, McNamee P, Thomas S, Jacoby A, Bates D A cost-utility analysis of interferon beta for multiple sclerosis Parkin D, Miller P, McNamee P, Thomas S, Jacoby A, Bates D Record Status This is a critical abstract of an economic evaluation that meets

More information

The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Schmier J K, Rachman N J, Halpern M T

The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Schmier J K, Rachman N J, Halpern M T The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Schmier J K, Rachman N J, Halpern M T Record Status This is a critical abstract of an economic evaluation that

More information

Drug Class Review Nonsteroidal Antiinflammatory Drugs (NSAIDs)

Drug Class Review Nonsteroidal Antiinflammatory Drugs (NSAIDs) Drug Class Review Nonsteroidal Antiinflammatory Drugs (NSAIDs) Final Update 4 Report November 2010 The purpose of the is to summarize key information contained in the Drug Effectiveness Review Project

More information

Authors' objectives To assess the value of treatments for foot ulcers in patients with Type 2 diabetes mellitus.

Authors' objectives To assess the value of treatments for foot ulcers in patients with Type 2 diabetes mellitus. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus - II: treatment Mason J, O'Keeffe C, Hutchinson A, McIntosh A, Young R, Booth A Authors' objectives To assess the value of treatments

More information

Papers. Abstract. Introduction. Methods. Jonathan J Deeks, Lesley A Smith, Matthew D Bradley

Papers. Abstract. Introduction. Methods. Jonathan J Deeks, Lesley A Smith, Matthew D Bradley Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials Jonathan J Deeks, Lesley

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,

More information

a newsletter detailing appropriate indications of IV PPI was sent to physicians;

a newsletter detailing appropriate indications of IV PPI was sent to physicians; Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions Kaplan G G, Bates D, McDonald D, Panaccione R, Romagnuolo J Record Status This is a critical abstract of an

More information

Meta-analyses: analyses:

Meta-analyses: analyses: Meta-analyses: analyses: how do they help, and when can they not? Lee Hooper Senior Lecturer in research synthesis & nutrition l.hooper@uea.ac.uk 01603 591268 Aims Systematic Reviews Discuss the scientific

More information

Study population The study population comprised a hypothetical cohort of patients with severe sepsis and septic shock.

Study population The study population comprised a hypothetical cohort of patients with severe sepsis and septic shock. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock Neilson A R, Burchardi H, Schneider H Record Status This is a critical abstract

More information

Treatment of Guillain-Barre syndrome: a cost-effectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R

Treatment of Guillain-Barre syndrome: a cost-effectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R Treatment of Guillain-Barre syndrome: a cost-effectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R Record Status This is a critical abstract of an economic evaluation that

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium ketoprofen/, 100mg/20mg; 200mg/20mg modified release capsules (Axorid ) No. (606/10) Meda Pharmaceuticals 05 February 2010 The Scottish Medicines Consortium (SMC) has completed

More information

Positron emission tomography Medicare Services Advisory Committee

Positron emission tomography Medicare Services Advisory Committee Positron emission tomography Medicare Services Advisory Committee Authors' objectives To assess the effectiveness of positron emission tomography (PET), the report addressed the following (truncated) six

More information

Outcomes assessed in the review

Outcomes assessed in the review The effectiveness of mechanical compression devices in attaining hemostasis after removal of a femoral sheath following femoral artery cannulation for cardiac interventional procedures Jones T Authors'

More information

Setting The setting was primary care. The economic analysis was conducted in Glasgow, UK.

Setting The setting was primary care. The economic analysis was conducted in Glasgow, UK. Helicobacter pylori eradication for peptic ulceration: an observational study in a Scottish primary care setting Forrest E H, MacKenzie J F, Stuart R C, Morris A J Record Status This is a critical abstract

More information

Study population Patients in the UK, with moderate and severe depression, and within the age range 18 to 93 years.

Study population Patients in the UK, with moderate and severe depression, and within the age range 18 to 93 years. Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Borghi J, Guest J F Record Status This is a critical abstract

More information

Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer Glick S, Wagner J L, Johnson C D

Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer Glick S, Wagner J L, Johnson C D Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer Glick S, Wagner J L, Johnson C D Record Status This is a critical abstract of an economic evaluation that meets the

More information

NSAIDs: Side Effects and Guidelines

NSAIDs: Side Effects and Guidelines NSAIDs: Side Effects and James J Hale FY1 Department of Anaesthetics Introduction The non-steroidal anti-inflammatory drugs (NSAIDs) are a diverse group of drugs that have analgesic, antipyretic and anti-inflammatory

More information

Setting The setting was an outpatients department. The economic study was carried out in the UK.

Setting The setting was an outpatients department. The economic study was carried out in the UK. Effectiveness and cost-effectiveness of three types of physiotherapy used to reduce chronic low back pain disability: a pragmatic randomized trial with economic evaluation Critchley D J, Ratcliffe J, Noonan

More information

Setting The setting was primary and secondary care. The economic study was carried out in Taiwan.

Setting The setting was primary and secondary care. The economic study was carried out in Taiwan. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries Wu G H, Wang Y W, Yen A M, Wong J M, Lai H C, Warwick J, Chen T H Record Status This

More information

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Perlroth D J, Sanders G D, Gould M K

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Perlroth D J, Sanders G D, Gould M K Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Perlroth D J, Sanders G D, Gould M K Record Status This is a critical abstract of an economic evaluation that meets

More information

Economic study type Cost-effectiveness analysis.

Economic study type Cost-effectiveness analysis. Use of standardised outcome measures in adult mental health services: randomised controlled trial Slade M, McCrone P, Kuipers E, Leese M, Cahill S, Parabiaghi A, Priebe S, Thornicroft G Record Status This

More information

The treatment of postnatal depression: a comprehensive literature review Boath E, Henshaw C

The treatment of postnatal depression: a comprehensive literature review Boath E, Henshaw C The treatment of postnatal depression: a comprehensive literature review Boath E, Henshaw C Authors' objectives To evalute treatments of postnatal depression. Searching MEDLINE, PsycLIT, Sociofile, CINAHL

More information

Pressure ulcers: guideline development and economic modelling Legood R, McInnes E

Pressure ulcers: guideline development and economic modelling Legood R, McInnes E Pressure ulcers: guideline development and economic modelling Legood R, McInnes E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each

More information

Drug Class Review on Proton Pump Inhibitors

Drug Class Review on Proton Pump Inhibitors Drug Class Review on Proton Pump Inhibitors Final Report Update 4 July 2006 Original Report Date: November 2002 Update 1 Report Date: April 2003 Update 2 Report Date: April 2004 Update 3 Report Date: May

More information

Setting The setting was tertiary care. The economic study was carried out in Turin, Italy.

Setting The setting was tertiary care. The economic study was carried out in Turin, Italy. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial Conrotto D, Carbone M, Carrozzo M, Arduino P, Broccoletti R,

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Coxib and traditional NSAID Trialists (CNT)

More information

Characteristics of selective and non-selective NSAID use in Scotland

Characteristics of selective and non-selective NSAID use in Scotland Characteristics of selective and non-selective NSAID use in Scotland Alford KMG 1, Simpson C 1, Williams D 2 1 Department of General Practice & Primary Care, The University of Aberdeen. 2 Department of

More information

Alcohol interventions in secondary and further education

Alcohol interventions in secondary and further education National Institute for Health and Care Excellence Guideline version (Draft for Consultation) Alcohol interventions in secondary and further education NICE guideline: methods NICE guideline Methods

More information

Cost-effectiveness analysis of different strategies for treating duodenal ulcer Badia X, Segu J L, Olle A, Brosa M, Mones J, Ponte L G

Cost-effectiveness analysis of different strategies for treating duodenal ulcer Badia X, Segu J L, Olle A, Brosa M, Mones J, Ponte L G Cost-effectiveness analysis of different strategies for treating duodenal ulcer Badia X, Segu J L, Olle A, Brosa M, Mones J, Ponte L G Record Status This is a critical abstract of an economic evaluation

More information

Health technology Serological testing and endoscopy with biopsy for suspected peptic ulcer disease.

Health technology Serological testing and endoscopy with biopsy for suspected peptic ulcer disease. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis Fendrick A M, Chernew M E, Hirth R A, Bloom

More information

Celecoxib: the need to know for safe prescribing

Celecoxib: the need to know for safe prescribing medicine indications pain management rheumatology Celecoxib: the need to know for safe prescribing Celecoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor that has been fully subsidised without restriction,

More information

Health technology The use of ultrasonography in the diagnosis and management of developmental hip dysplasia.

Health technology The use of ultrasonography in the diagnosis and management of developmental hip dysplasia. Ultrasonography in the diagnosis and management of developmental hip dysplasia (UK Hip Trial): clinical and economic results of a multicentre randomised controlled trial Elbourne D, Dezateux, Arthur R,

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews The effect of probiotics on functional constipation: a systematic review of randomised controlled trials EIRINI DIMIDI, STEPHANOS CHRISTODOULIDES,

More information

Type of intervention Screening. Economic study type Cost-effectiveness analysis.

Type of intervention Screening. Economic study type Cost-effectiveness analysis. Prospective, randomized, single-blind comparison of two preparations for screening flexible sigmoidoscopy Bini E J, Unger J S, Rieber J M, Rosenberg J, Trujillo K, Weinshel E H Record Status This is a

More information

Setting The setting was primary care. The economic study was carried out in the USA.

Setting The setting was primary care. The economic study was carried out in the USA. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis Pignone M, Earnshaw S, Tice J A, Pletcher M J Record Status This is a critical

More information

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion

More information

Setting Community. The economic study was carried out in Cambridge, United Kingdom.

Setting Community. The economic study was carried out in Cambridge, United Kingdom. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population Pharoah

More information

Gastric ulcers at endoscopy: brush, biopsy, or both Sadowski D C, Rabeneck L

Gastric ulcers at endoscopy: brush, biopsy, or both Sadowski D C, Rabeneck L Gastric ulcers at endoscopy: brush, biopsy, or both Sadowski D C, Rabeneck L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Review title and timescale 1 Review title Give the working title of the review. This must be in English. Ideally it should state succinctly

More information

Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment

Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment Record Status This is a critical abstract of an economic evaluation that meets

More information

Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis.

Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery Gillespie E L, White C M, Kluger J, Sahni J, Gallagher R, Coleman C

More information

Cost-utility of initial medical management for Crohn's disease perianal fistulae Arseneau K O, Cohn S M, Cominelli F, Connors A F

Cost-utility of initial medical management for Crohn's disease perianal fistulae Arseneau K O, Cohn S M, Cominelli F, Connors A F Cost-utility of initial medical management for Crohn's disease perianal fistulae Arseneau K O, Cohn S M, Cominelli F, Connors A F Record Status This is a critical abstract of an economic evaluation that

More information

Month/Year of Review: January 2012 Date of Last Review: February 2007

Month/Year of Review: January 2012 Date of Last Review: February 2007 Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Month/Year of Review: January 2012 Date of Last Review:

More information

Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis Provenzale D, Wong J B, Onken J E, Lipscomb J

Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis Provenzale D, Wong J B, Onken J E, Lipscomb J Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis Provenzale D, Wong J B, Onken J E, Lipscomb J Record Status This is a critical abstract of an economic evaluation

More information

Setting The setting was secondary care. The economic study was carried out in the UK.

Setting The setting was secondary care. The economic study was carried out in the UK. Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility Pashayan N, Lyratzopoulos G, Mathur R

More information

Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E

Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

Outcomes assessed in the review The outcomes assessed in the review and used as model inputs were the incident rates of:

Outcomes assessed in the review The outcomes assessed in the review and used as model inputs were the incident rates of: The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes Scuffham P, Carr L Record Status This is a critical abstract of

More information

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis Choi H K, Seeger J D, Kuntz K M

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis Choi H K, Seeger J D, Kuntz K M A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis Choi H K, Seeger J D, Kuntz K M Record Status This is a critical abstract of an economic evaluation that meets

More information

An economic evaluation of rizatriptan in the treatment of migraine Thompson M, Gawel M, Desjardins B, Ferko N, Grima D

An economic evaluation of rizatriptan in the treatment of migraine Thompson M, Gawel M, Desjardins B, Ferko N, Grima D An economic evaluation of rizatriptan in the treatment of migraine Thompson M, Gawel M, Desjardins B, Ferko N, Grima D Record Status This is a critical abstract of an economic evaluation that meets the

More information

Economic implications of early treatment of migraine with sumatriptan tablets Cady R K, Sheftell F, Lipton R B, Kwong W J, O'Quinn S

Economic implications of early treatment of migraine with sumatriptan tablets Cady R K, Sheftell F, Lipton R B, Kwong W J, O'Quinn S Economic implications of early treatment of migraine with sumatriptan tablets Cady R K, Sheftell F, Lipton R B, Kwong W J, O'Quinn S Record Status This is a critical abstract of an economic evaluation

More information

CARDIOVASCULAR RISK and NSAIDs

CARDIOVASCULAR RISK and NSAIDs CARDIOVASCULAR RISK and NSAIDs Dr. Syed Ghulam Mogni Mowla Assistant Professor of Medicine Shaheed Suhrawardy Medical College, Dhaka INTRODUCTION NSAIDs are most commonly prescribed drugs Recent evidence

More information

Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis Wingard J R, Wood C A, Sullivan E, Berger M L, Gerth W C, Mansley E C

Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis Wingard J R, Wood C A, Sullivan E, Berger M L, Gerth W C, Mansley E C Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis Wingard J R, Wood C A, Sullivan E, Berger M L, Gerth W C, Mansley E C Record Status This is a critical abstract of an economic

More information

Setting The setting was secondary care. The economic study was conducted in Germany.

Setting The setting was secondary care. The economic study was conducted in Germany. Cost-effectiveness analysis of treatment of renal-artery stenoses by medication, angioplasty, stenting and surgery Duda S H, Banz K, Brehme U, Erley CM, Albes J, Tepe G, Wiskirchen J, Claussen C D Record

More information

A randomized crossover study of silver-coated urinary catheters in hospitalized patients Karchmer T B, Giannetta E T, Muto C A, Strain B A, Farr B M

A randomized crossover study of silver-coated urinary catheters in hospitalized patients Karchmer T B, Giannetta E T, Muto C A, Strain B A, Farr B M A randomized crossover study of silver-coated urinary catheters in hospitalized patients Karchmer T B, Giannetta E T, Muto C A, Strain B A, Farr B M Record Status This is a critical abstract of an economic

More information

Health technology The use of four-layer compression bandaging (4LB) versus alternative dressings for the treatment of venous ulcers.

Health technology The use of four-layer compression bandaging (4LB) versus alternative dressings for the treatment of venous ulcers. Randomized clinical trial and economic analysis of four-layer compression bandaging for venous ulcers O'Brien J F, Grace P A, Perry I J, Hannigan A, Clarke Moloney M, Burke P E Record Status This is a

More information

Setting The setting was primary care. The economic study was conducted in Canada.

Setting The setting was primary care. The economic study was conducted in Canada. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment - Helicobacter pylori positive (CADET-Hp) randomised controlled

More information

Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis Chung R C, Walters M R, Greenfield M L, Chernew M E

Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis Chung R C, Walters M R, Greenfield M L, Chernew M E Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis Chung R C, Walters M R, Greenfield M L, Chernew M E Record Status This is a critical abstract of an economic evaluation that

More information

A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis Das A

A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis Das A A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis Das A Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

Study population Patients with intermittent claudication or critical ischaemia due to an iliac arterial stenosis.

Study population Patients with intermittent claudication or critical ischaemia due to an iliac arterial stenosis. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty Bosch J L, Tetteroo E, Mali W P, Hunink M G Record Status This is a critical

More information

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of psoriasis vulgaris Peeters P, Ortonne

More information

Drug Class Review on Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Drug Class Review on Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs) Drug Class Review on Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs () UPDATED FINAL REPORT #1 September 2003 Mark Helfand, MD, MPH Oregon Evidence-based Practice Center Oregon

More information

Ambulatory endoscopic treatment of symptomatic benign endometrial polyps: a feasibility study Clark T J, Godwin J, Khan K S, Gupta J K

Ambulatory endoscopic treatment of symptomatic benign endometrial polyps: a feasibility study Clark T J, Godwin J, Khan K S, Gupta J K Ambulatory endoscopic treatment of symptomatic benign endometrial polyps: a feasibility study Clark T J, Godwin J, Khan K S, Gupta J K Record Status This is a critical abstract of an economic evaluation

More information

Setting The setting was primary care. The economic study was carried out in the UK and the USA.

Setting The setting was primary care. The economic study was carried out in the UK and the USA. Validation of venous leg ulcer guidelines in the United States and United Kingdom McGuckin M, Waterman R, Brooks J, Cherry G, Porten L, Hurley S, Kerstein M D Record Status This is a critical abstract

More information

A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus Swift J A, Conway P, Purdie D W

A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus Swift J A, Conway P, Purdie D W A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus Swift J A, Conway P, Purdie D W Record Status This is a critical abstract of an economic evaluation

More information